Delivery Order SPE2DB24D2101-SPE2DB24FKFWD

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of RINVOQ ER 30 MG TABLET UU 30S to the Defense Logistics Agency (DLA). The $43,254.69 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 21, 2024, with an ultimate completion date of October 22, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S pharmaceutical products to the Defense Logistics Agency (DLA). The $9,023.13 firm fixed price contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceuticals and medical supplies to the U.S. government. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,020.55 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 3, 2024 with a completion date of June 4, 2024. The contract is a delivery order and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,008.23 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 16, 2024 with a completion date of October 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The U.S. Department of Defense (DOD) Defense Logistics Agency (DLA) awarded a $14,048.42 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4566803438 - RINVOQ ER 15 MG TABLET UU 30S. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a comprehensive vehicle for supplying a range of pharmaceutical...
This federal contract award is for the delivery of RINVOQ ER 30 MG TABLET to the Defense Logistics Agency (DLA). The contract, valued at $22,109.60, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of December 17, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
This federal contract award is for the delivery of RINVOQ ER 30 MG TABLET UU 30S to the Defense Logistics Agency (DLA), a defense agency. The $45,404.89 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 10, 2024 with a completion date of June 11, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a vehicle for providing a...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,223.32 firm fixed-price delivery order is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET pharmaceutical products to the Defense Logistics Agency (DLA). The $85,119.42 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 18, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $13,727.88 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation specializing in pharmaceutical sourcing and distribution. This contract is a child award under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKFWD
    Delivery Order

This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The $21,123.58 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and is associated with the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is set to be completed by August 14, 2024.

Generated 11/12/24, 9:07 AM